CID 131769929

2-hydroxynevirapine glucuronide

Structural Information

Molecular Formula
C21H22N4O8
SMILES
CC1=CC(=NC2=C1NC(=O)C3=C(N2C4CC4)N=CC=C3)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O
InChI
InChI=1S/C21H22N4O8/c1-8-7-11(32-21-15(28)13(26)14(27)16(33-21)20(30)31)23-18-12(8)24-19(29)10-3-2-6-22-17(10)25(18)9-4-5-9/h2-3,6-7,9,13-16,21,26-28H,4-5H2,1H3,(H,24,29)(H,30,31)/t13-,14-,15+,16-,21+/m0/s1
InChIKey
RNMZKTLILDCQOC-KUSYAZKWSA-N
Compound name
(2S,3S,4S,5R,6S)-6-[(2-cyclopropyl-7-methyl-10-oxo-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-5-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

0
References

3
Patents

458.14377 Da
Monoisotopic Mass

0.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 459.15105 212.9
[M+Na]+ 481.13299 220.2
[M-H]- 457.13649 215.6
[M+NH4]+ 476.17759 209.5
[M+K]+ 497.10693 219.7
[M+H-H2O]+ 441.14103 203.0
[M+HCOO]- 503.14197 215.9
[M+CH3COO]- 517.15762 217.0
[M+Na-2H]- 479.11844 210.6
[M]+ 458.14322 211.7
[M]- 458.14432 211.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe